Abstract
<jats:p>As chronic non-communicable diseases (NCDs) reach epidemic proportions globally, traditional episodic care models remain insufficient, necessitating a shift toward continuous, technology-driven management. This narrative review critically assesses the clinical utility of telemedicine interventions—specifically continuous glucose monitoring, remote hypertension surveillance, and implantable hemodynamic sensors—while examining the persistent socio-technical barriers impeding their widespread adoption. Based on a comprehensive synthesis of literature from PubMed/MEDLINE, Scopus, and Google Scholar (2020–2025), this study contrasts clinical efficacy with implementation realities. The evidence confirms that while telemedical tools consistently surpass conventional care in stabilizing metabolic control and lowering hospitalization rates, their long-term viability is compromised by the "Digital Divide 2.0"—a phenomenon defined by deficits in digital literacy and usability challenges among the elderly. Moreover, the analysis identifies systemic bottlenecks, including fragmented data standardization and the exclusion of patient-generated health data from routine workflows. Ethical tensions surrounding algorithmic paternalism and surveillance fatigue are also highlighted as critical factors affecting patient autonomy. Ultimately, bridging the gap between digital capability and sustainable practice requires moving beyond technological determinism toward a holistic strategy that integrates policy innovation, human-centered design, and ethical data governance.</jats:p>